- Changes in the Korean Journal of Blood Transfusion over Three Years (2021 to 2023)
-
Choi SJ, Lim J
- KMID: 2549678
- Korean J Blood Transfus.
- 2023 Dec;34(3):165-170.
- doi: 10.17945/kjbt.2023.34.3.165
The Korean Journal of Blood Transfusion (KJBT) stands as a prominent publication in the field of transfusion medicine, playing a pivotal role in advancing both national blood management projects and... -
- CITED
-
- Close
- SHARE
-
- Close
- Suggestion to Use Optimal ABO Non-Identical but Compatible RBC Components in Emergency/Massive Transfusions: Are Type O RBC the Second Best for Type AB Patients?
-
Lee HR
- KMID: 2549684
- Korean J Blood Transfus.
- 2023 Dec;34(3):214-217.
- doi: 10.17945/kjbt.2023.34.3.214
According to the transfusion guidelines, type O RBC is the best choice for emergency transfusions if the recipient’s ABO group is unknown. If the recipient’s ABO group is confirmed after... -
- CITED
-
- Close
- SHARE
-
- Close
- Report on Unexpected Antibodies Detected Exclusively in the Serum
-
Jung BK, Chung YN, Park J
- KMID: 2549683
- Korean J Blood Transfus.
- 2023 Dec;34(3):211-213.
- doi: 10.17945/kjbt.2023.34.3.211
In 2023, an 81-year-old woman requested a preliminary red blood cell transfusion during pancreatic cancer surgery, and antibody screening was performed using automated blood typing equipment. The antibody screening test... -
- CITED
-
- Close
- SHARE
-
- Close
- Suggestion for Reducing the Platelet Content Requirements of Apheresis Platelet in Korea
-
Lee HJ, Jang JS
- KMID: 2549685
- Korean J Blood Transfus.
- 2023 Dec;34(3):218-221.
- doi: 10.17945/kjbt.2023.34.3.218
In the United States, it was announced that when the platelet count standard for apheresis platelets was changed from 3.0×1011 /unit to 2.5×1011 /unit, the total supply of platelet products... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Unexpected Antibody Frequency in Korea by Department: Focusing on Obstetrics and Infertility Centers
-
Shin WY, Kim HJ, Paek J, Shin JW
- KMID: 2549680
- Korean J Blood Transfus.
- 2023 Dec;34(3):182-188.
- doi: 10.17945/kjbt.2023.34.3.182
Background: Alloantibodies against red blood cells (RBC) found in pregnant women can cause hemolytic disease in the fetus and newborn (HDFN). Therefore, checking and carefully observing the mother’s unexpected alloantibodies... -
- CITED
-
- Close
- SHARE
-
- Close
- Unexpected Antibody Identification Experienced by a Referral Laboratory for Medical Testing
-
Kim BS
- KMID: 2549682
- Korean J Blood Transfus.
- 2023 Dec;34(3):198-210.
- doi: 10.17945/kjbt.2023.34.3.198
Background: We report the identification of unexpected antibodies by a referral laboratory during medical tests conducted on samples from small hospitals and clinics nationwide. Methods: From June 2021 to March 2023,... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Column Agglutination Technique and Tube Test for ABO Antibody Titration and Crossmatching
-
Lim YA
- KMID: 2549681
- Korean J Blood Transfus.
- 2023 Dec;34(3):189-197.
- doi: 10.17945/kjbt.2023.34.3.189
Background: ABO Ab titration using Erytra Eflexis (Diagnostic Grifols, Barcelona, Spain, abbreviated as Eflexis) and a pretransfusion crossmatching using DG Gel Coombs Card (Diagnostic Grifols, abbreviated as Card) were compared... -
- CITED
-
- Close
- SHARE
-
- Close
- Daratumumab-Induced Interference in Flow-Cytometry Crossmatch and Resolving It by DTT Treatment
-
Lee JK, Jeong IH, Kang N, Jeong M, Song HB, Park JW, Kang ES
- KMID: 2549679
- Korean J Blood Transfus.
- 2023 Dec;34(3):171-181.
- doi: 10.17945/kjbt.2023.34.3.171
Background: Daratumumab is a human monoclonal antibody targeting CD38 used widely in various related conditions. Caution is advised when interpreting the pretransfusion tests in daratumumab-treated patients because they may show... -
- CITED
-
- Close
- SHARE
-
- Close
